Clinical Report: Molecular Indicators of Pulmonary Fibrosis in BALF and Saliva

Overview

This review examines molecular biomarkers in bronchoalveolar lavage fluid (BALF) and saliva related to pulmonary fibrosis, particularly idiopathic pulmonary fibrosis (IPF).

Background

Pulmonary fibrosis, especially IPF, poses significant health risks and is associated with progressive lung function decline. The identification of molecular biomarkers in BALF and saliva could enhance diagnostic strategies for interstitial lung diseases.

Data Highlights

No numerical data or trial results were provided in the source material.

Key Findings

• Molecular biomarkers such as type I collagen, hydroxyproline, and KL-6 are relevant for pulmonary fibrosis diagnosis.
• Bronchoalveolar lavage fluid (BALF) can provide insights into inflammatory processes and tissue damage in IPF.
• Saliva may serve as a non-invasive medium for monitoring biomarkers associated with lung diseases.
• Current methodologies for detecting biomarkers in BALF and saliva have advantages and limitations.
• There is a lack of standardized protocols for sampling and analytical normalization in studies involving BALF and saliva.

Clinical Implications

The findings suggest that integrating molecular biomarkers from BALF and saliva could improve the diagnostic and prognostic capabilities for pulmonary fibrosis. However, further research is needed to establish standardized methods for their use in clinical settings.

Conclusion

This review underscores the importance of exploring molecular indicators in BALF and saliva for pulmonary fibrosis, while also highlighting the need for further studies to fill existing knowledge gaps.

Related Resources & Content

1. Frontiers, 2026 -- Biomarkers of Pulmonary Fibrosis in Bronchioalveolar Lavage Fluid and Saliva. Study Methods and Pathophysiological Significance.
2. American Journal of Respiratory and Critical Care Medicine, 2022 -- Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline.
3. npj Digital Medicine — Metagenomic fingerprints in bronchoalveolar lavage differentiate pulmonary diseases
4. Infection — Assessment of soluble urokinase plasminogen activator receptor (suPAR) levels in bronchoalveolar lavage fluid and serum among critically ill patients: A prospective cohort analysis
5. Intensive Care Medicine — Elevated Levels of Laminin γ2 Fragments Detected in the Blood of Patients with Early Acute Lung Injury
6. The Journal of Infectious Diseases — Performance of mp-tNGS in Bronchoalveolar Lavage Fluid for the Diagnosis of Invasive Pulmonary Aspergillosis in Nonneutropenic Patients
7. Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline | American Journal of Respiratory and Critical Care Medicine
8. Inhaled Treprostinil for Idiopathic Pulmonary Fibrosis | New England Journal of Medicine
9. Frontiers | Biomarkers of Pulmonary Fibrosis in Bronchioalveolar Lavage Fluid and Saliva. Study Methods and Pathophysiological Significance.